Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	66.43B
Revenue (ttm)	21.10B
Net Income (ttm)	3.08B
Shares Out	124.17M
EPS (ttm)	24.04
PE Ratio	16.41
Forward PE	13.01
Dividend	11.67 (2.18%)
Ex-Dividend Date	Jun 20, 2025

Volume	301,043
Average Volume	1,213,926
Open	533.00
Previous Close	535.00
Day's Range	530.00 - 537.00
52-Week Range	468.42 - 795.00
Beta	0.70
RSI	33.83
Earnings Date	Nov 12, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 36
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.